Article
No association between COMT Val158Met polymorphism and prostate cancer risk: a meta-analysis.
Genetic testing and molecular biomarkers - 1 Jan 2013
Zou Li-wei, Xu Xiao-juan, Liu Ting, Wang Han-yong, Fan Wen-jing, Wang Xing-hua, Zhang Zhao-xiang, Zhai Jin-xia
Abstract excerpt
OBJECTIVE: Results from published studies on the association between the catechol-O-methyltransferase (COMT) Val158Met polymorphism and prostate cancer (PCa) risk are inconsistent. To derive a more precise estimate, we performed a meta-analysis. METHODS: We searched in the PubMed and Elsevier Science Direct database for studies on the association between the COMT Val158Met polymorphism and PCa. We used the odds...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
